thalidomide has been researched along with Lymphatic Diseases in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Waldenström macroglobulinemia is defined by the presence of monoclonal immunoglobulin IgM type (M-IgM) and evidence of lymphoplasmacytic bone marrow infiltration." | 2.53 | [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience]. ( Adam, Z; Král, Z; Krejčí, M; Mayer, J; Pour, L; Pourová, E; Ševčíková, E; Ševčíková, S, 2016) |
| "Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder of unknown etiology." | 1.32 | Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide. ( Lee, FC; Merchant, SH, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, RS | 1 |
| Di Stasi, A | 1 |
| Hosing, C | 1 |
| Shah, N | 1 |
| Rezvani, K | 1 |
| Alousi, A | 1 |
| O'Brien, S | 1 |
| Wierda, W | 1 |
| Keating, M | 1 |
| Shpall, EJ | 1 |
| Adam, Z | 1 |
| Pour, L | 1 |
| Krejčí, M | 1 |
| Ševčíková, S | 1 |
| Pourová, E | 1 |
| Ševčíková, E | 1 |
| Král, Z | 1 |
| Mayer, J | 1 |
| Lee, FC | 1 |
| Merchant, SH | 1 |
1 review available for thalidomide and Lymphatic Diseases
| Article | Year |
|---|---|
[Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Topics: Adenine; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protoc | 2016 |
2 other studies available for thalidomide and Lymphatic Diseases
| Article | Year |
|---|---|
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.
Topics: Aged; Bone Marrow; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immuno | 2014 |
Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
Topics: Adult; Anemia; Antibodies, Viral; Axilla; Biopsy; Castleman Disease; Cytokines; Female; Herpesvirus | 2003 |